Change language dansk English suomi svenska

Generate Estimates Confirm Cancel Hide empty rows Show hidden rows DummyText

DR GULVE ApS Estimate generation in progress, please wait... 0%

Quicksearch from your own companies XBRLDenmark Analyst: XBRLDenmark

Loading... Loading... Loading... Loading...   Loading...

1000.0 Bankruptcy Risk  2018 2018/9 2019 2019/9 2020 2020/9 2021 2021/9 2022 2022/9 2023 2023/9 2024e N/A 2025e N/A Bankruptcy risk for industry   1.5% 1.5% 1.5% 1.5% 1.5% 1.5% 7.6% 7.6%   Bankruptcy risk   1.3% 2.0% 1.0% 1.1% 1.2% 1.0% 9.9% 9.7%   Credit score (0-100)   82 70 86 83 82 84 25 26   Credit rating   A A A A A A BB BB   Credit limit (kDKK)   164.3 0.5 521.0 276.9 250.3 475.7 0.0 0.0   How are these values calculated?   View the automatically generated explanation of bankruptcy risk 1000.0 Income statement (kDKK)  2018 2018/9 2019 2019/9 2020 2020/9 2021 2021/9 2022 2022/9 2023 2023/9 2024e N/A 2025e N/A Net sales   0 0 0 0 0 0 0 0   Gross profit   10,956 7,855 11,134 9,463 12,596 11,563 0.0 0.0   EBITDA   4,610 1,580 3,932 2,210 4,272 3,725 0.0 0.0   EBIT   4,541 1,525 3,862 2,156 4,233 3,699 0.0 0.0   Pre-tax profit (PTP)   4,374.6 1,374.3 3,746.1 2,053.5 4,119.2 3,655.9 0.0 0.0   Net earnings   3,409.1 1,070.6 2,919.4 1,601.4 3,209.1 2,846.8 0.0 0.0   Pre-tax profit without non-rec. items   4,375 1,374 3,746 2,054 4,119 3,656 0.0 0.0     See the entire income statement 1000.0 Balance sheet (kDKK)  2018 2018/9 2019 2019/9 2020 2020/9 2021 2021/9 2022 2022/9 2023 2023/9 2024e N/A 2025e N/A Tangible assets total   243 266 197 102 92.1 224 0.0 0.0   Shareholders equity total   4,501 2,171 4,591 3,292 4,901 4,548 1,623 1,623   Interest-bearing liabilities   0.5 38.0 0.5 0.5 16.3 0.5 0.0 0.0   Balance sheet total (assets)   8,261 6,260 8,638 8,111 8,289 8,492 1,623 1,623   Net Debt   -3,364 -1,143 -3,468 -2,895 -2,911 -1,438 -1,623 -1,623     See the entire balance sheet 1000.0 Volume  2018 2018/9 2019 2019/9 2020 2020/9 2021 2021/9 2022 2022/9 2023 2023/9 2024e N/A 2025e N/A Net sales   0 0 0 0 0 0 0 0   Net sales growth   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Gross profit   10,956 7,855 11,134 9,463 12,596 11,563 0.0 0.0   Gross profit growth   41.0% -28.3% 41.7% -15.0% 33.1% -8.2% -100.0% 0.0%   Employees   14 14 15 14 15 14 0 0   Employee growth %   16.7% 0.0% 7.1% -6.7% 7.1% -6.7% -100.0% 0.0%   Employee expenses   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Balance sheet total (assets)   8,261 6,260 8,638 8,111 8,289 8,492 1,623 1,623   Balance sheet change%   -18.9% -24.2% 38.0% -6.1% 2.2% 2.4% -80.9% 0.0%   Added value   4,540.9 1,525.0 3,862.2 2,156.5 4,232.7 3,699.5 0.0 0.0   Added value %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Investments   -139 -32 -139 -148 -49 107 -224 0   Net sales trend   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   EBIT trend   3.0 4.0 5.0 5.0 5.0 5.0 0.0 0.0   1000.0 Profitability  2018 2018/9 2019 2019/9 2020 2020/9 2021 2021/9 2022 2022/9 2023 2023/9 2024e N/A 2025e N/A EBITDA %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   EBIT %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   EBIT to gross profit (%)   41.4% 19.4% 34.7% 22.8% 33.6% 32.0% 0.0% 0.0%   Net Earnings %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Profit before depreciation and extraordinary items %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Pre tax profit less extraordinaries %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   ROA %   49.2% 21.0% 51.8% 25.8% 51.6% 44.5% 0.0% 0.0%   ROI %   114.0% 45.1% 112.3% 54.3% 102.5% 78.6% 0.0% 0.0%   ROE %   89.2% 32.1% 86.4% 40.6% 78.3% 60.3% 0.0% 0.0%   1000.0 Solidity  2018 2018/9 2019 2019/9 2020 2020/9 2021 2021/9 2022 2022/9 2023 2023/9 2024e N/A 2025e N/A Equity ratio %   54.5% 34.7% 53.1% 40.6% 59.1% 53.6% 100.0% 100.0%   Relative indebtedness %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Relative net indebtedness %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Net int. bear. debt to EBITDA, %   -73.0% -72.3% -88.2% -131.0% -68.1% -38.6% 0.0% 0.0%   Gearing %   0.0% 1.8% 0.0% 0.0% 0.3% 0.0% 0.0% 0.0%   Net interest   0 0 0 0 0 0 0 0   Financing costs %   110.3% 782.1% 602.8% 20,016.5% 1,352.1% 935.7% 0.0% 0.0%   1000.0 Liquidity  2018 2018/9 2019 2019/9 2020 2020/9 2021 2021/9 2022 2022/9 2023 2023/9 2024e N/A 2025e N/A Quick Ratio   2.1 1.5 2.0 1.6 3.1 2.5 0.0 0.0   Current Ratio   2.1 1.5 2.1 1.7 3.1 2.5 0.0 0.0   Cash and cash equivalent   3,364.5 1,180.9 3,468.2 2,895.1 2,927.5 1,438.8 0.0 0.0   1000.0 Capital use efficiency  2018 2018/9 2019 2019/9 2020 2020/9 2021 2021/9 2022 2022/9 2023 2023/9 2024e N/A 2025e N/A Trade debtors turnover (days)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Trade creditors turnover (days)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Current assets / Net sales %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Net working capital   4,271.6 1,948.8 4,430.0 3,218.9 5,575.9 5,021.1 0.0 0.0   Net working capital %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   1000.0 Employee efficiency  2018 2018/9 2019 2019/9 2020 2020/9 2021 2021/9 2022 2022/9 2023 2023/9 2024e N/A 2025e N/A Net sales / employee   0 0 0 0 0 0 0 0   Added value / employee   324 109 257 154 282 264 0 0   Employee expenses / employee   0 0 0 0 0 0 0 0   EBITDA / employee   329 113 262 158 285 266 0 0   EBIT / employee   324 109 257 154 282 264 0 0   Net earnings / employee   244 76 195 114 214 203 0 0